This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Analysts' Actions: COF, EA, NYX, MAKO

NEW YORK (TheStreet) -- CHANGE IN RATINGS

AAR Corp. (AIR) was downgraded to Hold at TheStreet Ratings.

Aecom Technology (ACM) was downgraded at Bank of America/Merrill Lynch to Underperform. $20 price target. Company lacks near-term catalysts and is a potential value trap, BofA/Merrill said.

Capital One (COF) was upgraded at Argus from Sell to Hold. Valuation call.

Cognizant (CTSH) was upgraded from Neutral to Outperform at Robert Baird. Valuation call, based on a $76 price target, Baird said.

Dresser-Rand (DRC) was upgraded at Morgan Stanley from Equal-Weight to Overweight. $65 price target. Lower natural gas prices are boosting demand for downstream activity, Morgan Stanley said.

Electronic Arts (EA) was upgraded at Needham from Hold to Buy. $22 price target. Strong sales growth can expand margins, Needham said.

Goldman Sachs (GS) was downgraded to Hold at TheStreet Ratings.

HSN (HSNI) was upgraded at Citigroup to Buy from Neutral. $42.50 price target. Compelling valuation and accelerating buyback, Citi said.

Louisiana-Pacific (LPX) was upgraded at Deutsche Bank from Hold to Buy. $12 price target. Housing demand is beginning to recover, Deutsche said.

Mako Surgical (MAKO) was downgraded at William Blair to Market Perform. Estimates were also cut, given the company's new guidance, William Blair said.

Millennial Media (MM) was initiated with an Equal-weight rating at Morgan Stanley. Valuation call, Morgan Stanley said.

NYSE Euronext (NYX) was upgraded at Stifel Nicolaus from Sell to Hold. Valuation call, Stifel Nicolaus said.

Rexnord (RXN) was initiated with a Neutral rating at Goldman Sachs. Valuation call, based on a $24 price target, Goldman said.

Synchronoss (SNCR) was downgraded at Wells Fargo to Market Perform. Company cut its guidance because of AT&T (T), Wells Fargo said.

Vertex Pharmaceuticals (VRTX) was upgraded at Morgan Stanley from Underweight to Equal-Weight. $51 price target. Interim cystic fibrosis data were better than expected, Morgan Stanley said.

Vertex Pharmaceuticals was upgraded at Brean Murray. Cystic Fibrosis treatment is performing better than expected in trials. Brean Murray said.

Exco Resources (XCO) was upgraded at Keybanc from Hold to Buy. $10 price target. Stock has underperformed, but the company is getting aggressive with its cost controls, Keybanc said.

Cimarex Energy (XEC) was upgraded at Canaccord Genuity from Hold to Buy. $84 price target. Stock is attractive, following a 20% decline, Canaccord said.

1 of 2

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 16,915.07 -70.54 -0.42%
S&P 500 1,964.68 -8.15 -0.41%
NASDAQ 4,396.2040 -22.83 -0.52%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto
Advertising Partners

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs